Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: The Hong Kong diabetes registry

BMC Endocrine Disorders

Volumn 14, Issue 1, 2014, Pages

  Kong, Alice P S ^a   Yang, Xilin ^a,b   Luk, Andrea ^a,c   Cheung, Kitty K T ^a   Ma, Ronald C W ^a   So, Wing Yee ^a   Ho, Chung Shun ^d   Chan, Michael H M ^d   Ozaki, Risa ^a   Chow, Chun Chung ^a   Brown, Nicola ^c   Chan, Juliana C N ^a,c,e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Asia Diabetes Foundation   (China)

^d Department of Chemical Pathology ^*  (China)

^e Department of Anatomical and Cellular Pathology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DEATH; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HONG KONG; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; DEATH; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84902054399     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-48     Document Type: Article

References (39)

1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-89. 10.1056/NEJMoa0806470, 18784090.
2. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370(9590):829-40. 10.1016/S0140-6736(07)61303-8, 17765963.
3. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-59.
4. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, Abraira C, Duckworth WC, Paul C, Arca D, Cason L, Martinez Zolotor R, Williams L, Collier SL, Ahmed N, Boyd A, Reda D, Moritz T, Anderson R, Vitek ME, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139. 10.1056/NEJMoa0808431, 19092145.
5. Home P. Safety of very tight blood glucose control in type 2 diabetes. BMJ 2008, 336(7642):458-9. 10.1136/bmj.39499.514410.80, 2258341, 18309965.
6. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010, 340:b4909. 10.1136/bmj.b4909, 2803744, 20061358.
7. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010, 363(15):1410-8. 10.1056/NEJMoa1003795, 20925543.
8. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005, 28(12):2948-2961. 10.2337/diacare.28.12.2948, 16306561.
9. Ayodele OE, Alebiosu CO, Salako BL. Diabetic nephropathy-a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 2004, 96(11):1445-1454. 2568593, 15586648.
10. Wu AY, Kong NC, De Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005, 48(1):17-26. 10.1007/s00125-004-1599-9, 15616801.
11. Kong AP, So WY, Szeto CC, Chan NN, Luk A, Ma RC, Ozaki R, Ng VW, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC. Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 2006, 69(2):383-387. 10.1038/sj.ki.5000061, 16408130.
12. Yang X, So WY, Tong PC, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong VC, Chan JC. Development and validation of an all-cause mortality risk score in type 2 diabetes. Arch Intern Med 2008, 168(5):451-457. 10.1001/archinte.168.5.451, 18332288.
13. Kong AP, Yang X, Ko GT, So WY, Chan WB, Ma RC, Ng VW, Chow CC, Cockram CS, Tong PC, Wong V, Chan JC. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care 2007, 30(4):953-959. 10.2337/dc06-2443, 17259475.
14. Kong AP, Yang X, Luk A, Ma RC, So WY, Ozaki R, Ting R, Cheung K, Ho CS, Chan MH, Chow CC, Chan JC. Severe hypoglycemia identifies vulnerable patients with Type 2 diabetes at risk for premature death and all-site cancer: The Hong Kong Diabetes Registry. Diabetes Care 2014, 37:1-8.
15. Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M, . For the DiabCare Monitoring Group of the St. Vincent Declaration Steering Committee Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DiabCare initiative. Diabet Med 1993, 10:371-377. 10.1111/j.1464-5491.1993.tb00083.x, 8508624, For the DiabCare Monitoring Group of the St. Vincent Declaration Steering Committee.
16. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17(10):2937-2944. Epub 2006 Sep 20, 10.1681/ASN.2006040368, 16988059.
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002, 39:S1-S246. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
18. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol 2007, 17(3):227-236. 10.1016/j.annepidem.2006.10.009, 17320789.
19. Lin DY, Wei LJ, Ying Z. Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals. Biometrika 1993, 80(3):557-572.
20. Yang X, Kong AP, Luk AO, Ozaki R, Ko GT, Ma RC, Chan JC, So WY. Validation of Methods to Control for Immortal Time Bias in a Pharmacoepidemiologic Analysis of Renin -Angiotensin System Inhibitors in Type 2 Diabetes. J Epidemiol 2014, Apr 19. [Epub ahead of print]. DOI: 10.2188/jea.JE20130164.
21. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005, 20(7):575-579. 10.1007/s10654-005-7835-x, 16119429.
22. Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, Hasslocher-Moreno A, Sousa AS, Scanavacca MI. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006, 355(8):799-808. 10.1056/NEJMoa053241, 16928995.
23. Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S. The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Diabetes Metab Res Rev 2010, 26(4):239-244. 10.1002/dmrr.1092, 20503255.
24. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010, 33(6):1389-1394. 10.2337/dc09-2082, 2875462, 20508232.
25. Raz I, Riddle MC, Rosenstock J, Buse JB, Inzucchi SE, Home PD, Del Prato S, Ferrannini E, Chan JC, Leiter LA, Leroith D, Defronzo R, Cefalu WT. Personalized management of hyperglycemia in type 2 diabetes: Reflections from a diabetes care editors' expert forum. Diabetes care. 2013, 36:1779-1788. 10.2337/dc13-0512, 3661796, 23704680.
26. UKPDS Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UKPDS.
27. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009, 4(6):1121-1127. 10.2215/CJN.00800209, 2689888, 19423569.
28. Ma RC, Kong AP, Chan N, Tong PC, Chan JC. Drug-induced endocrine and metabolic disorders. Drug Saf 2007, 30(3):215-245. 10.2165/00002018-200730030-00005, 17343430.
29. So WY, Chan JC, Yeung VT, Chow CC, Ko GT, Li JK, Cockram CS. Sulphonylurea-induced hypoglycaemia in institutionalized elderly in Hong Kong. Diabet Med 2002, 19(11):966-968. 10.1046/j.1464-5491.2002.00807_1.x, 12421437.
30. Luk AO, Yang X, Ma RC, Ng VW, Yu LW, Lau WW, Ozaki R, Chow FC, Kong AP, Tong PC, Chan JC, So W. Association of statin use and development of renal dysfunction in type 2 diabetes-the Hong Kong Diabetes Registry. Diabetes Res Clin Pract 2010, 88(3):227-233. 10.1016/j.diabres.2010.02.006, 20236720.
31. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, De Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375(9731):2073-2081. 3993088, 20483451.
32. Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, Ma RC, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes mellitus. Diabetes Care 2006, 29(11):2439-2444. 10.2337/dc06-0887, 17065681.
33. So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006, 29(9):2046-2052. 10.2337/dc06-0248, 16936151.
34. Fouque D, Pelletier S, Mafra D, Chauveau P. Nutrition and chronic kidney disease. Kidney Int 2011, 80(4):348-357. 10.1038/ki.2011.118, 21562470.
35. Palesty JA, Dudrick SJ. Cachexia, malnutrition, the refeeding syndrome, and lessons from Goldilocks. Surg Clin North Am 2011, 91(3):653-673. 10.1016/j.suc.2011.02.007, 21621702.
36. Yang X, So WY, Ma RC, Kong AP, Xu G, Chan JC. Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2012, 28(5):379-87. 10.1002/dmrr.2287, 22318884.
37. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J, . Emerging Risk Factors Collaboration Diabetes mellitus, fasting sugar, and risk of cause-specific death. N Engl J Med 2011, 364(9):829-41. 4109980, 21366474, Emerging Risk Factors Collaboration.
38. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004, 148(1):99-104. 10.1016/j.ahj.2004.02.013, 15215798.
39. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005, 43(5):480-485. 10.1097/01.mlr.0000160417.39497.a9, 15838413.